Reference health

SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases

https://doi.org/10.1136/annrheumdis-2021-220461
CiteStamped reference-health badge
14/14 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 14 checked references that resolve
resolves10.1136/bmj.m1198
Covid-19: risk factors for severe disease and death
resolves10.1056/NEJMoa2034577
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
resolves10.1056/NEJMoa2035389
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
resolves10.1056/NEJMoa2028436
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
resolves10.1038/s41586-020-2814-7
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
resolves10.1136/annrheumdis-2013-204223
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)
resolves10.1038/s41586-020-2521-4
Factors associated with COVID-19-related death using OpenSAFELY
resolves10.1136/rmdopen-2019-001035
Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations
resolves10.1136/annrheumdis-2021-220272
Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
resolves10.1038/s41467-020-17703-6
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion
resolves10.1136/annrheumdis-2020-219808
SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease
resolves10.1038/nrendo.2012.206
Gonadal steroids and humoral immunity
resolves10.1038/s41577-020-0348-8
Considering how biological sex impacts immune responses and COVID-19 outcomes
resolves10.1038/s41586-020-2550-z
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
The 1 reference without a DOI — listed, not checked
no DOI — not checkedAmerican College of Rheumatology Guidance for COVID-19 Vaccination in Patients with Rheumatic and Musculoskeletal Diseases - Version 1
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1136/annrheumdis-2021-220461"><img src="https://citestamp.com/citestamped/10.1136/annrheumdis-2021-220461/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1136/annrheumdis-2021-220461/badge.svg)](https://citestamp.com/citestamped/10.1136/annrheumdis-2021-220461)